These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 28912574)

  • 1. Distinct gut microbiome patterns associate with consensus molecular subtypes of colorectal cancer.
    Purcell RV; Visnovska M; Biggs PJ; Schmeier S; Frizelle FA
    Sci Rep; 2017 Sep; 7(1):11590. PubMed ID: 28912574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MinION Sequencing of colorectal cancer tumour microbiomes-A comparison with amplicon-based and RNA-Sequencing.
    Taylor WS; Pearson J; Miller A; Schmeier S; Frizelle FA; Purcell RV
    PLoS One; 2020; 15(5):e0233170. PubMed ID: 32433701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila as a four-bacteria biomarker panel of colorectal cancer.
    Osman MA; Neoh HM; Ab Mutalib NS; Chin SF; Mazlan L; Raja Ali RA; Zakaria AD; Ngiu CS; Ang MY; Jamal R
    Sci Rep; 2021 Feb; 11(1):2925. PubMed ID: 33536501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metagenomics and transcriptomics data from human colorectal cancer.
    Visnovska T; Biggs PJ; Schmeier S; Frizelle FA; Purcell RV
    Sci Data; 2019 Jul; 6(1):116. PubMed ID: 31278253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer.
    Yu J; Feng Q; Wong SH; Zhang D; Liang QY; Qin Y; Tang L; Zhao H; Stenvang J; Li Y; Wang X; Xu X; Chen N; Wu WK; Al-Aama J; Nielsen HJ; Kiilerich P; Jensen BA; Yau TO; Lan Z; Jia H; Li J; Xiao L; Lam TY; Ng SC; Cheng AS; Wong VW; Chan FK; Xu X; Yang H; Madsen L; Datz C; Tilg H; Wang J; Brünner N; Kristiansen K; Arumugam M; Sung JJ; Wang J
    Gut; 2017 Jan; 66(1):70-78. PubMed ID: 26408641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parvimonas micra forms a distinct bacterial network with oral pathobionts in colorectal cancer patients.
    Löwenmark T; Köhn L; Kellgren T; Rosenbaum W; Bronnec V; Löfgren-Burström A; Zingmark C; Larsson P; Dahlberg M; Schroeder BO; Wai SN; Ljuslinder I; Edin S; Palmqvist R
    J Transl Med; 2024 Oct; 22(1):947. PubMed ID: 39420333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The multispecies microbial cluster of Fusobacterium, Parvimonas, Bacteroides and Faecalibacterium as a precision biomarker for colorectal cancer diagnosis.
    Conde-Pérez K; Aja-Macaya P; Buetas E; Trigo-Tasende N; Nasser-Ali M; Rumbo-Feal S; Nión P; Arribas EM; Estévez LS; Otero-Alén B; Noguera JF; Concha Á; Pardiñas-López S; Carda-Diéguez M; Gómez-Randulfe I; Martínez-Lago N; Ladra S; Aparicio LMA; Bou G; Mira Á; Vallejo JA; Poza M
    Mol Oncol; 2024 May; 18(5):1093-1122. PubMed ID: 38366793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers.
    Dai Z; Coker OO; Nakatsu G; Wu WKK; Zhao L; Chen Z; Chan FKL; Kristiansen K; Sung JJY; Wong SH; Yu J
    Microbiome; 2018 Apr; 6(1):70. PubMed ID: 29642940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic impact of consensus molecular subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial.
    Mooi JK; Wirapati P; Asher R; Lee CK; Savas P; Price TJ; Townsend A; Hardingham J; Buchanan D; Williams D; Tejpar S; Mariadason JM; Tebbutt NC
    Ann Oncol; 2018 Nov; 29(11):2240-2246. PubMed ID: 30247524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodiversity and richness shifts of mucosa-associated gut microbiota with progression of colorectal cancer.
    Pan HW; Du LT; Li W; Yang YM; Zhang Y; Wang CX
    Res Microbiol; 2020; 171(3-4):107-114. PubMed ID: 31982498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.
    Senthakumaran T; Moen AEF; Tannæs TM; Endres A; Brackmann SA; Rounge TB; Bemanian V; Tunsjø HS
    Eur J Clin Microbiol Infect Dis; 2023 Mar; 42(3):305-322. PubMed ID: 36703031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consensus molecular subtype classification of colorectal adenomas.
    Komor MA; Bosch LJ; Bounova G; Bolijn AS; Delis-van Diemen PM; Rausch C; Hoogstrate Y; Stubbs AP; de Jong M; Jenster G; van Grieken NC; Carvalho B; Wessels LF; Jimenez CR; Fijneman RJ; Meijer GA;
    J Pathol; 2018 Nov; 246(3):266-276. PubMed ID: 29968252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A modified protein marker panel to identify four consensus molecular subtypes in colorectal cancer using immunohistochemistry.
    Li X; Larsson P; Ljuslinder I; Ling A; Löfgren-Burström A; Zingmark C; Edin S; Palmqvist R
    Pathol Res Pract; 2021 Apr; 220():153379. PubMed ID: 33721619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enrichment of Prevotella intermedia in human colorectal cancer and its additive effects with Fusobacterium nucleatum on the malignant transformation of colorectal adenomas.
    Lo CH; Wu DC; Jao SW; Wu CC; Lin CY; Chuang CH; Lin YB; Chen CH; Chen YT; Chen JH; Hsiao KH; Chen YJ; Chen YT; Wang JY; Li LH
    J Biomed Sci; 2022 Oct; 29(1):88. PubMed ID: 36303164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of TSPAN8 in consensus molecular subtype 3 colorectal cancer.
    Suwatthanarak T; Tanjak P; Chaiboonchoe A; Acharayothin O; Thanormjit K; Chanthercrob J; Suwatthanarak T; Niyomchan A; Tanaka M; Okochi M; Pongpaibul A; Chalermwai WV; Trakarnsanga A; Methasate A; Pithukpakorn M; Chinswangwatanakul V
    Exp Mol Pathol; 2024 Jun; 137():104911. PubMed ID: 38861838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parvimonas micra is associated with tumour immune profiles in molecular subtypes of colorectal cancer.
    Löwenmark T; Li X; Löfgren-Burström A; Zingmark C; Ling A; Kellgren TG; Larsson P; Ljuslinder I; Wai SN; Edin S; Palmqvist R
    Cancer Immunol Immunother; 2022 Oct; 71(10):2565-2575. PubMed ID: 35301576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiome confounders and quantitative profiling challenge predicted microbial targets in colorectal cancer development.
    Tito RY; Verbandt S; Aguirre Vazquez M; Lahti L; Verspecht C; Lloréns-Rico V; Vieira-Silva S; Arts J; Falony G; Dekker E; Reumers J; Tejpar S; Raes J
    Nat Med; 2024 May; 30(5):1339-1348. PubMed ID: 38689063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusobacterium nucleatum in biopsied tissues from colorectal cancer patients and alcohol consumption in Korea.
    Kim M; Lee ST; Choi S; Lee H; Kwon SS; Byun JH; Kim YA; Rhee KJ; Choi JR; Kim TI; Lee K
    Sci Rep; 2020 Nov; 10(1):19915. PubMed ID: 33199749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metagenomic analysis of colonic tissue and stool microbiome in patients with colorectal cancer in a South Asian population.
    Gamage BD; Ranasinghe D; Sahankumari A; Malavige GN
    BMC Cancer; 2024 Sep; 24(1):1124. PubMed ID: 39256724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiome compositional and functional differences between tumor and non-tumor adjacent tissues from cohorts from the US and Spain.
    Allali I; Delgado S; Marron PI; Astudillo A; Yeh JJ; Ghazal H; Amzazi S; Keku T; Azcarate-Peril MA
    Gut Microbes; 2015; 6(3):161-72. PubMed ID: 25875428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.